ALTEROLA BIOTECH INC. Quarterly Common Stock, Shares, Issued from Q4 2009 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Alterola Biotech Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2009 to Q3 2024.
  • Alterola Biotech Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 1.47B shares, a 88.6% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.47B +689M +88.6% Sep 30, 2024 10-Q 2024-11-29
Q2 2024 1.47B +660M +81.8% Jun 30, 2024 10-Q/A 2024-11-25
Q1 2024 1.38B +576M +71.3% Mar 31, 2024 10-Q 2024-11-29
Q4 2023 1.38B +576M +71.3% Dec 31, 2023 10-Q/A 2024-02-21
Q3 2023 778M -29M -3.6% Sep 30, 2023 10-Q 2024-11-29
Q2 2023 807M +4.41M +0.55% Jun 30, 2023 10-Q/A 2024-11-25
Q1 2023 807M +4.13M +0.52% Mar 31, 2023 10-Q 2024-11-29
Q4 2022 807M +20.7M +2.64% Dec 31, 2022 10-Q/A 2024-02-21
Q3 2022 807M +45.3M +5.94% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 803M +48.4M +6.41% Jun 30, 2022 10-Q 2022-08-18
Q1 2022 803M +48.6M +6.45% Mar 31, 2022 10-Q/A 2024-02-21
Q4 2021 786M +653M +490% Dec 31, 2021 10-Q 2022-03-01
Q3 2021 762M +632M +486% Sep 30, 2021 10-Q 2022-11-21
Q2 2021 754M +637M +545% Jun 30, 2021 10-Q 2021-08-19
Q1 2021 754M +637M +545% Mar 31, 2021 10-K/A 2022-09-14
Q4 2020 133M +16.2M +13.8% Dec 31, 2020 10-Q 2021-05-28
Q3 2020 130M +13M +11.1% Sep 30, 2020 10-KT 2021-06-09
Q2 2020 117M +1M +0.86% Jun 30, 2020 10-Q 2021-05-14
Q1 2020 117M +1M +0.86% Mar 31, 2020 10-Q 2021-05-13
Q4 2019 117M +1M +0.86% Dec 31, 2019 10-Q 2021-04-02
Q3 2019 117M +1M +0.86% Sep 30, 2019 10-KT 2021-06-09
Q2 2019 116M 0 0% Jun 30, 2019 10-Q 2021-03-09
Q1 2019 116M +1M +0.87% Mar 31, 2019 10-Q 2021-02-24
Q4 2018 116M +1M +0.87% Dec 31, 2018 10-Q 2020-12-29
Q3 2018 116M +1M +0.87% Sep 30, 2018 10-K 2021-03-26
Q2 2018 116M +1M +0.87% Jun 30, 2018 10-Q 2020-10-07
Q1 2018 115M 0 0% Mar 31, 2018 10-Q 2019-01-24
Q4 2017 115M 0 0% Dec 31, 2017 10-Q 2019-01-11
Q3 2017 115M 0 0% Sep 30, 2017 10-K 2020-12-14
Q2 2017 115M 0 0% Jun 30, 2017 10-Q 2018-09-10
Q1 2017 115M 0 0% Mar 31, 2017 10-Q 2018-09-06
Q4 2016 115M 0 0% Dec 31, 2016 10-Q 2018-08-30
Q3 2016 115M 0 0% Sep 30, 2016 10-K 2018-12-17
Q2 2016 115M 0 0% Jun 30, 2016 10-Q 2018-08-06
Q1 2016 115M 0 0% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 115M 0 0% Dec 31, 2015 10-Q 2016-02-05
Q3 2015 115M 0 0% Sep 30, 2015 10-K 2018-08-30
Q2 2015 115M 0 0% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 115M 0 0% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 115M 0 0% Dec 31, 2014 10-Q 2015-02-23
Q3 2014 115M +37M +47.4% Sep 30, 2014 10-K 2015-12-30
Q2 2014 115M +37M +47.4% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 115M +37M +47.4% Mar 31, 2014 10-Q 2014-05-20
Q4 2013 115M +37M +47.4% Dec 31, 2013 10-Q 2014-05-14
Q3 2013 78M 0 0% Sep 30, 2013 10-Q 2015-05-08
Q2 2013 78M 0 0% Jun 30, 2013 10-Q 2014-03-17
Q1 2013 78M 0 0% Mar 31, 2013 10-Q 2014-03-17
Q4 2012 78M 0 0% Dec 31, 2012 10-Q 2014-03-17
Q3 2012 78M 0 0% Sep 30, 2012 10-K 2014-05-13
Q2 2012 78M 0 0% Jun 30, 2012 10-Q 2014-03-07
Q1 2012 78M Mar 31, 2012 10-Q 2014-03-07
Q4 2011 78M Dec 31, 2011 10-Q 2014-03-05
Q3 2011 78M -14.8M -15.9% Sep 30, 2011 10-K 2014-03-11
Q2 2011 78M Jun 30, 2011 10-Q 2013-09-06
Q3 2010 92.7M Sep 30, 2010 10-K 2014-02-27
Q1 2010 55M May 3, 2010 10-Q 2014-05-20
Q4 2009 33.3M Jan 5, 2010 10-Q 2018-08-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.